New Ruipeng Pet Group Inc. (RPET)
New Ruipeng Pet Group was planning to go public, but the IPO was withdrawn on Jun 6, 2024.
Stock Price: Pending
IPO price not available yet

Company Description

New Ruipeng Pet Group is the largest pet care platform in China and the second largest globally in terms of number of hospitals and revenue from pet care services in both 2020 and 2021.

We have operated in the pet care industry for over 20 years and are the oldest national pet hospital chain operator in China.

Since our inception, we have built a digitalized pet care platform covering the full lifecycle of pets, and remained true and dedicated to making pets healthier and providing superior pet care services.

Through operation experience accumulated over the years, we have achieved rapid network expansion across pet care services, supply chain services and local services through a combination of organic growth and acquisitions.

By September 30, 2022, we had 1,942 pet hospitals in 114 cities across China. We operate pet care services, supply chain services, and local services as three pillars, and have expanded into other business segments including third-party diagnosis, continued veterinary education and marketing-as-a-service.

We have thus become the leading one-stop pet care platform in China in terms of number of pet hospitals, revenue and service scope providing integrated services to pets and pet parents.

New Ruipeng Pet Group Inc.
Country China
Founded 1998
Industry Healthcare
Sector Medical Care Facilities
Employees 19,237
CEO Yonghe Peng

Contact Details

Address:
11F, Building B, Kingkey Timemark
No.9289 Binhe Boulevard, Futian District, Shenzhen, Guangdong Province 518042
China
Phone +86 755-8398-6686
Website ruipengpet.com

Stock Details

Ticker Symbol RPET
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency CNY
CIK Code 0001841931
SIC Code 0700

Key Executives

Name Position
Yonghe Peng Director, Co-Chairman and President
Liang Li Director and Co-Chairman
Lang Liu Director
Yanzhong Zhang Director
Liesheng Wang Director
Tieming Yu Director
Shanwei Wei Director
Bing Xiao Director
Shenghao Shi Director
Chenguang Zhou Chief Financial Officer

Latest SEC Filings

Date Type Title
Jun 6, 2024 RW Filing
Mar 14, 2023 F-1/A [Amend] Registration statement for certain foreign private issuers
Feb 2, 2023 F-1/A [Amend] Registration statement for certain foreign private issuers
Jan 23, 2023 F-1 Registration statement for certain foreign private issuers
Dec 27, 2022 DRS/A [Amend] [Cover] Draft Registration Statement
Oct 7, 2022 DRS/A [Amend] [Cover] Draft Registration Statement
Sep 15, 2022 DRS/A [Amend] [Cover] Draft Registration Statement
May 17, 2022 DRS/A [Amend] [Cover] Draft Registration Statement
Sep 20, 2021 DRS/A [Amend] [Cover] Draft Registration Statement
Jul 30, 2021 DRS/A [Amend] [Cover] Draft Registration Statement